Pool Corporation (NASDAQ:POOL), is not the largest company out there, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to ...

Zcash edges lower by 4% on Friday, threatening the 50-day EMA at $435. Stagnation in shielded ZEC tokens signals a deceleration in demand for privacy coins. The rising retail volume in the futures and ...

In the second quarter of 2025, Berkshire's 13F filing revealed that Buffett and his team of investors increased their position in Pool Corp stock by 136%. That increase followed the first quarter, ...

Pool Corp's stock is currently trading at its lowest level since Buffett began buying in Q3 2024. Shares have slipped lower over concerns about the weak housing market. Pool may experience near-term ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Wealth management M&A has run hot since 2021. Even when the Federal Reserve raised interest rates 11 times over a roughly 16-month span beginning in March 2022, the impact was relatively ...

SMCI has surged 46% from its $30 base, confirming a structural setup ahead of Nvidia’s Blackwell-driven H2 supercycle. Whale activity shows $2.5M in call buying near $47, while $400M in dark pool ...

Exhausted buying enthusiasm, followed by intense selling, can trigger a market correction or meltdown. Markets and index ETFs often peak on low-volume days with reduced price volatility. Then, ...

Buffett and company have started buying a stock that's been swimming circles around the market for decades. Legendary investor and billionaire Warren Buffett invests through his holding company, ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

The rules for statin and blood pressure (BP) medication initiation may need to be rewritten if a new and improved cardiovascular risk prediction tool is broadly implemented, research suggested. Use of ...